VISTEON SVP sells 3,000 shares under 10b5-1 plan
VISTEON CORP Senior Vice President Robert R. Vallance reported open-market sales of company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VISTEON CORP Senior Vice President Robert R. Vallance reported open-market sales of company common stock. He sold 2,000 shares on June 1, 2026 at an average price of $116.50 per share and 1,000 shares on June 2, 2026 at $119.40 per share, for total reported sales of 3,000 shares. After these transactions, he directly held 17,469 shares of Visteon common stock. The filing states the trades were made under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026, indicating they were scheduled in advance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,000 | $119.40 | $119K |
| Sale | Common Stock | 2,000 | $116.50 | $233K |
Footnotes (1)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did VISTEON CORP (VC) report for Robert R. Vallance?
Were the VISTEON CORP (VC) insider sales made under a Rule 10b5-1 trading plan?
What type of transactions did VISTEON CORP (VC) disclose in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.